NR 508 (NR 508)
Kaplan University
Here are the best resources to pass NR 508 (NR 508). Find NR 508 (NR 508) study guides, notes, assignments, and much more.
All 15 results
Sort by:
-
Exam (elaborations)
nr test bank pharmacology Prescriptive Authority and Role Implementation: Tradition vs. Change Test Bank
-
---248November 20212021/2022A
- Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs. Change 
Test Bank 
MULTIPLE CHOICE 
1. Which of the following has influenced an emphasis on primary care education in medical 
schools? 
a. Changes in Medicare reimbursement 
methods recommended in 1992 
b. Competition from nonphysicians desiring 
to meet primary care shortages 
c. The need for monopolistic control in the 
marketplace of primary outpatient care 
d. The recognition that nonphysicians have 
variable suc...
-
$16.49 More Info
GradeProfessor
-
Exam (elaborations)
NR 508 Midterm Exam - Advanced Pharm with Answers (100% CORRECT)
-
---27July 20212020/2021A
- 1. A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: 
 
2. A patient who has hyperlipidemia has been taking atorvastatin (Lipitor) 60 mg daily for 6 months. The patient’s initial lipid profile showed LDL of 180 mg/dL, HDL of 45 m...
-
$15.99 More Info
Precision
-
Exam (elaborations)
NR 508 - Week 5 Exam.//Exam (elaborations) NR 508 (NR508WEEK5EXAM.) (NR 508 (NR508WEEK5EXAM.))
-
---14January 20212020/2021A+
- NR 508 | NR508 Week 5 
 
Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: 
1. Cortical bones 
2. Femoral neck bones 
3. Cervical vertebrae 
4. Pelvic bones 
2. Femoral neck bones 
Bisphosphonates treat or prevent osteoporosis by: 
1. Inhibiting osteoclastic activity 
2. Fostering bone resorption 
3. Enhancing calcium uptake in the bone 
4. Strengthening the osteoclastic proton pump 
1. Inhibiting osteoclastic activity 
Prophylactic us...
-
$14.97 More Info
Rubricguru
-
Exam (elaborations)
NR 508 - Week 7 Exam
-
---8January 20212020/2021A+
- NR 508 - Week 7 Exam /NR 508 - Week 7 Exam. 
Digoxin levels need to be monitored closely when the following medication is started: 
4. Albuterol 
Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? 
2. Beta-2-agonists 
Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all? 
2. Salmeterol, an inhaled long-act...
-
$13.39 More Info
bestnurse
-
Exam (elaborations)
NR 508 - Week 5 Exam.
-
---14January 20212020/2021A+
- NR 508 - Week 5 Exam/NR 508 - Week 5 Exam. 
Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: 
Bisphosphonates treat or prevent osteoporosis by:
-
$15.49 More Info
bestnurse
-
Exam (elaborations)
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3).
-
---27January 20212020/2021A+
- NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3). 
A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:
-
$15.99 More Info
bestnurse